The study also found that high expression levels of LincRNA H19, miR-675, MRP3, HOXA1, and MMP16 were more common in patients with early-stage breast cancer (TNM stages I or II) and those diagnosed with invasive ductal carcinoma (IDC), suggesting their utility as early diagnostic markers to facilitate the early detection and treatment of IDC. Here, MMP16 is linked to invasive ductal breast carcinoma.